Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Regulatory News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

21 Aug 2018 15:28

RNS Number : 4726Y
Sensyne Health PLC
21 August 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Sensyne Health Ltd

Sedol BYV3J75

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Placing of shares

X

3. Details of person subject to the notification obligationiv

Name

1Lansdowne Partners International Limited

2Lansdowne Partners Limited

3Lansdowne Partners (UK) LLP

4Lansdowne Developed Markets Master Fund Limited

 

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

Aurora Nominees Ltd

Morgan Stanley Client Securities Nominees Ltd

(Registered Shareholders)

City and country of registered office (if applicable)

n/a

5. Date on which the threshold was crossed or reachedvi:

17/08/2018

6. Date on which issuer notified (DD/MM/YYYY):

20/08/2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

10.41%

10.41%

128,571,514

Position of previous notification (if

applicable)

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BYV3J755

13,384,497

10.41%

SUBTOTAL 8. A

13,384,497

10.41%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Lansdowne Partners

International Limited

10.41%

10.41%

Lansdowne Partners

Limited

Lansdowne Partners (UK) LLP

10.41%

10.41%

Lansdowne Developed Markets Master Fund Limited

9.03%

9.03%

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

London

Date of completion

20 August 2018

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLZMGZRDMVGRZM
Date   Source Headline
5th Feb 20217:00 amRNSManagement appointments
3rd Feb 20217:00 amRNSLaunch of AI algorithm for patient management
21st Jan 20217:00 amRNSSensyne Health Interim Results
20th Jan 20217:00 amRNSSensyne signs SRA with Wolverhampton NHS Trust
19th Jan 202111:06 amRNSHolding(s) in Company
15th Jan 20214:41 pmRNSSecond Price Monitoring Extn
15th Jan 20214:36 pmRNSPrice Monitoring Extension
14th Jan 20217:00 amRNSSensyne launches MagnifEye smartphone app
13th Jan 20212:58 pmRNSHolding(s) in Company
11th Jan 20217:00 amRNSNotice of Interim Results
7th Jan 20215:12 pmRNSHolding(s) in Company
7th Jan 20215:09 pmRNSHolding(s) in Company
4th Jan 20213:06 pmRNSResult of General Meeting & Fundraising Completion
4th Jan 20213:05 pmRNSResult of Open Offer
18th Dec 20207:00 amRNSSensyne Health appoints Non-Executive Director
15th Dec 20207:00 amRNSLaunch of First Digital Health Product in the US
14th Dec 20207:00 amRNSPublication of Circular and General Meeting Notice
9th Dec 202011:06 amRNSSecond Price Monitoring Extn
9th Dec 202011:01 amRNSPrice Monitoring Extension
9th Dec 20209:05 amRNSSecond Price Monitoring Extn
9th Dec 20209:00 amRNSPrice Monitoring Extension
9th Dec 20207:00 amRNSSuccessful completion of Fundraise
8th Dec 20205:36 pmRNSProposed Fundraising
25th Nov 20207:00 amRNSSensyne Health Agreement with Hampshire NHS Trust
17th Nov 20202:05 pmRNSSecond Price Monitoring Extn
17th Nov 20202:00 pmRNSPrice Monitoring Extension
16th Nov 20207:02 amRNSSensyne Health achieves 5 million patient target
16th Nov 20207:00 amRNSSensyne Health Agreement with Somerset NHS Trust
13th Nov 20207:00 amRNSSensyne Health appoints President, North America
2nd Nov 20207:00 amRNSCOVID-19 testing study at University of Oxford
30th Oct 20204:33 pmRNSResult of AGM
28th Oct 20207:00 amRNSSensyne Health Agreement with Microsoft
26th Oct 20207:00 amRNSSensyne Health Agreement with Milton Keynes UH
23rd Oct 20207:00 amRNSSensyne Health agreement with Bristol Myers Squibb
6th Oct 20207:00 amRNSAnnual Report and Accounts and Notice of AGM
5th Oct 20204:40 pmRNSSecond Price Monitoring Extn
5th Oct 20204:35 pmRNSPrice Monitoring Extension
1st Oct 20206:07 pmRNSHolding(s) in Company
1st Oct 20202:00 pmRNSAgreement with NHS Greater Glasgow and Clyde
30th Sep 20201:12 pmRNSCollaboration with the University of Oxford
30th Sep 20207:01 amRNSSensyne Health Long Term Incentive Plan
30th Sep 20207:00 amRNSSensyne Health Full Year Results
29th Sep 202011:55 amRNSHolding(s) in Company
29th Sep 20209:46 amRNSHolding(s) in Company
23rd Sep 20207:00 amRNSNotice of Full Year Results
10th Sep 20207:00 amRNSSensyne Health appoints Chief Operating Officer
3rd Sep 20207:00 amRNSUK launch of ‘SENSE’ in partnership with Microsoft
20th Aug 20209:05 amRNSSecond Price Monitoring Extn
20th Aug 20209:00 amRNSPrice Monitoring Extension
19th Aug 20202:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.